(Q55242609)

28 June 2018

title

Biological significance of the antibody response to HIV antigens expressed on the cell surface. (English)

1 reference

28 June 2018

1 reference

J Goudsmit

1

1 reference

28 June 2018

K Ljunggren

2

1 reference

28 June 2018

L Smit

3

1 reference

28 June 2018

M Jondal

4

1 reference

28 June 2018

E M Fenyö

5

1 reference

28 June 2018

publication date

1 January 1988

1 reference

28 June 2018

published in

Archives of Virology

1 reference

28 June 2018

volume

103

1 reference

28 June 2018

issue

3-4

1 reference

28 June 2018

page(s)

189-206

1 reference

28 June 2018

https://scigraph.springernature.com/pub.10.1007/bf01311092

exact match

0 references

cites work

HTLV-III-neutralizing antibodies in patients with AIDS and AIDS-related complex

1 reference

12 December 2020

Variable and conserved neutralization antigens of human immunodeficiency virus

1 reference

12 December 2020

Role of the HTLV-III/LAV envelope in syncytium formation and cytopathicity

1 reference

12 December 2020

Detection of antibodies which mediate human immunodeficiency virus-specific cellular cytotoxicity (ADCC) in vitro

1 reference

12 December 2020

Three-year prospective study of HTLV-III/LAV infection in homosexual men.

1 reference

12 December 2020

Role of envelope glycoprotein carbohydrate in human immunodeficiency virus (HIV) infectivity and virus-induced cell fusion

1 reference

12 December 2020

Antibodies to HTLV-III in Swiss patients with AIDS and pre-AIDS and in groups at risk for AIDS.

1 reference

12 December 2020

pH-independent HIV entry into CD4-positive T cells via virus envelope fusion to the plasma membrane

1 reference

12 December 2020

Common region on chromosome 14 in T-cell leukemia and lymphoma

1 reference

12 December 2020

Sera from HTLV-III/LAV antibody-positive individuals mediate antibody-dependent cellular cytotoxicity against HTLV-III/LAV-infected T cells.

1 reference

12 December 2020

Lack of cross-reaction in antibody-dependent cellular cytotoxicity between human immunodeficiency virus (HIV) and HIV-related West African strains.

1 reference

12 December 2020

Identification and antigenicity of the major envelope glycoprotein of lymphadenopathy-associated virus

1 reference

12 December 2020

HTLV-III/LAV infection in nine children infected by a single plasma donor: clinical outcome and recognition patterns of viral proteins

1 reference

12 December 2020

Epitopes of the CD4 antigen and HIV infection

1 reference

12 December 2020

Productive HTLV-III infection of human B cell lines.

1 reference

12 December 2020

Immunological changes in lymphadenopathy virus positive and negative symptomless male homosexuals: two years of observation

1 reference

12 December 2020

HIV antigenaemia and virus isolation from plasma during primary HIV infection

1 reference

12 December 2020

Alterations in T4 (CD4) protein and mRNA synthesis in cells infected with HIV

1 reference

12 December 2020

Neutralization of human T-lymphotropic virus type III by sera of AIDS and AIDS-risk patients

1 reference

12 December 2020

Restricted neutralization of divergent human T-lymphotropic virus type III isolates by antibodies to the major envelope glycoprotein

1 reference

12 December 2020

Human antibody response to a strain-specific HIV-1 gp120 epitope associated with cell fusion inhibition.

1 reference

12 December 2020

Human immunodeficiency virus infection in two cohorts of homosexual men: neutralising sera and association of anti-gag antibody with prognosis

1 reference

12 December 2020

HIV isolation from plasma of HIV-infected persons

1 reference

12 December 2020

Distinct IgG recognition patterns during progression of subclinical and clinical infection with lymphadenopathy associated virus/human T lymphotropic virus

1 reference

12 December 2020

1 reference

12 December 2020

Antibody-dependent cellular cytotoxicity-inducing antibodies against human immunodeficiency virus. Presence at different clinical stages

1 reference

12 December 2020

Neutralizing antibodies to visna lentivirus: mechanism of action and possible role in virus persistence

1 reference

12 December 2020

Establishment and characterization of a human histiocytic lymphoma cell line (U-937)

1 reference

12 December 2020

Antigenemia and antibody titers to core and envelope antigens in AIDS, AIDS-related complex, and subclinical human immunodeficiency virus infection

1 reference

12 December 2020

Persistent HIV antigenaemia and decline of HIV core antibodies associated with transition to AIDS

1 reference

12 December 2020

Long-term seropositivity for human T-lymphotropic virus type III in homosexual men without the acquired immunodeficiency syndrome: development of immunologic and clinical abnormalities. A longitudinal study

1 reference

12 December 2020

Binding of HTLV-III/LAV to T4+ T cells by a complex of the 110K viral protein and the T4 molecule

1 reference

12 December 2020

Expression of human immunodeficiency virus antigen (HIV-Ag) in serum and cerebrospinal fluid during acute and chronic infection

1 reference

12 December 2020

Pathogenesis of HIV and its implications for serodiagnosis and monitoring of antiviral therapy

1 reference

12 December 2020

Human T-cell lymphotropic virus IIIB glycoprotein (gp120) bound to CD4 determinants on normal lymphocytes and expressed by infected cells serves as target for immune attack

1 reference

12 December 2020

Binding of the human retrovirus HTLV-III/LAV/ARV/HIV to the CD4 (T4) molecule: conformation dependence, epitope mapping, antibody inhibition, and potential for idiotypic mimicry

1 reference

12 December 2020

Temporal development of cross-neutralization between HTLV-III B and HTLV-III RF in experimentally infected chimpanzees.

1 reference

12 December 2020

Induction of CD4-dependent cell fusion by the HTLV-III/LAV envelope glycoprotein.

1 reference

12 December 2020

A simple method for detecting HIV antibodies hidden in circulating immune complexes

1 reference

12 December 2020

Viral gene expression, antibody production and immune complex formation in human immunodeficiency virus infection

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01311092

1 reference

28 June 2018

Dimensions Publication ID

1032997234

0 references

1 reference

28 June 2018